Substituted imidazopyridazines
AssigneesBayer Intellectual Property GmbH, Bayer Pharma Aktiengesellschaft
InventorsMarcus Koppitz, Ulrich Klar, Antje Margret Wengner, Roland Neuhaus, Gerhard Siemeister
Life of this patent
Estimating the term…
Loading patent…
AssigneesBayer Intellectual Property GmbH, Bayer Pharma Aktiengesellschaft
InventorsMarcus Koppitz, Ulrich Klar, Antje Margret Wengner, Roland Neuhaus, Gerhard Siemeister
Estimating the term…
The present invention relates to substituted imidazopyridazine compounds of general formula I in which R3, R5 and A are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
A compound of general formula I:
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.